Wiland Direct members can apply their models to the Breakthrough T1D file allowing them to reach their ideal target audience. Names will be delivered net of the mailer's house file providing incremental names to be applied in the merge.
The Breakthrough T1D is the world's leading nonprofit, non- governmental founder of diabetes research. Founded in 1970 by parents of children with diabetes, Breakthrough T1D's mission is to find a cure for diabetes and its complications through the support of research.
These Breakthrough T1D donors are caring, compassionate consumers whose contributions support the organization’s mission of funding Type 1 Diabetes (T1D) research. Breakthrough T1D collaborates with a wide spectrum of partners and is the only organization with the scientific resources, regulatory influence, and a working plan to better treat, prevent, and eventually cure T1D.
Facts About Breakthrough T1D and Diabetes:
• Since its founding in 1970, Breakthrough T1D has awarded more than $1.7 billion to diabetes research.
• More than 80 percent of Breakthrough T1D’s expenditures directly support research and research-related education. Breakthrough T1D maintains one of the best records among nonprofits of using supporters’ contributions effectively.
• Diabetes currently affects more than 371 million people worldwide and is expected to affect 552 million by 2030.
• In the U.S., a new case of diabetes is diagnosed every 30 seconds; more than 1.9 million people are diagnosed each year.
• Americans with diabetes incur medical expenses that are approximately 2.3 times higher than those incurred by Americans without diabetes.
All orders cancelled after merge and/or mail date will be billed at full rental rate. Orders cancelled prior to merge will be billed a $150/F fee plus $10/M run charges and all applicable selection charges. List owner/manager needs to be notified of any cut backs or cancellations before the merge happens.
|
